Ann: Ceasing to be a substantial holder, page-3

BNO have a long history of getting a partner (usually Merck) early in each drug development. That was one of the things that appealed to me - it made BNO relatively low risk, and gave the confidence that someone cluey had some sort of faith in their endeavours. They have gone a bit further on their own, this time, presumably because they have high confidence (I don't think they tried to get a partner this time but I may be wrong). Time will tell. I'm in for the ride, anyway. Well, for now .....